Christiane Winkler
Overview
Explore the profile of Christiane Winkler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1914
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hummel S, Friedl N, Winkler C, Ziegler A, Achenbach P
Diabetologia
. 2023 Sep;
66(12):2389-2390.
PMID: 37723346
No abstract available.
12.
Hummel S, Carl J, Friedl N, Winkler C, Kick K, Stock J, et al.
Diabetologia
. 2023 Jun;
66(9):1633-1642.
PMID: 37329450
Aims/hypothesis: We aimed to determine whether disease severity was reduced at onset of clinical (stage 3) type 1 diabetes in children previously diagnosed with presymptomatic type 1 diabetes in a...
13.
Badpa M, Schneider A, Ziegler A, Winkler C, Haupt F, Wolf K, et al.
Environ Res
. 2023 Jun;
232:116325.
PMID: 37271437
Background: Emerging evidence supports an association between light at night (LAN) exposure with obesity or overweight in adults. However, effects of LAN exposure during childhood have yet to be further...
14.
Badpa M, Wolf K, Schneider A, Winkler C, Haupt F, Peters A, et al.
Environ Res
. 2023 May;
231(Pt 2):116179.
PMID: 37216713
No abstract available.
15.
Frohnert B, Ghalwash M, Li Y, Ng K, Dunne J, Lundgren M, et al.
Diabetes Care
. 2023 Mar;
46(10):1753-1761.
PMID: 36862942
Objective: To estimate the risk of progression to stage 3 type 1 diabetes based on varying definitions of multiple islet autoantibody positivity (mIA). Research Design And Methods: Type 1 Diabetes...
16.
Shuck S, Achenbach P, Roep B, Termini J, Hernandez-Castillo C, Winkler C, et al.
Front Endocrinol (Lausanne)
. 2023 Feb;
14:1108910.
PMID: 36742390
Introduction: Progression to type 1 diabetes has emerged as a complex process with metabolic alterations proposed to be a significant driver of disease. Monitoring products of altered metabolism is a...
17.
Houben J, Janssens M, Winkler C, Besser R, Dzygalo K, Fehn A, et al.
Pediatr Diabetes
. 2022 Nov;
23(8):1707-1716.
PMID: 36323590
Introduction: This study examined the emotional impact that parents experience when confronted with an increased genetic risk of type 1 diabetes (T1D) in their child. Population-based screening of neonates for...
18.
Weiss A, Zapardiel-Gonzalo J, Voss F, Jolink M, Stock J, Haupt F, et al.
Diabetologia
. 2022 Oct;
65(12):2175.
PMID: 36194252
No abstract available.
19.
Bendor-Samuel O, Wishlade T, Willis L, Aley P, Choi E, Craik R, et al.
Arch Dis Child
. 2022 Sep;
108(1):26-30.
PMID: 36171064
Objective: INGR1D (INvestigating Genetic Risk for type 1 Diabetes) was a type 1 diabetes (T1D) genetic screening study established to identify participants for a primary prevention trial (POInT, Primary Oral...
20.
Weiss A, Zapardiel-Gonzalo J, Voss F, Jolink M, Stock J, Haupt F, et al.
Diabetologia
. 2022 Aug;
65(12):2121-2131.
PMID: 36028774
Aims/hypothesis: The aim of this study was to develop strategies that identify children from the general population who have late-stage presymptomatic type 1 diabetes and may, therefore, benefit from immune...